Seguir
Susanne Petri
Susanne Petri
Professorin für Neurologie, Medizinische Hochschule Hannover
Email confirmado em mh-hannover.de
Título
Citado por
Citado por
Ano
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
KP Lesch, D Bengel, A Heils, SZ Sabol, BD Greenberg, S Petri, ...
Science 274 (5292), 1527-1531, 1996
66111996
Allelic variation of human serotonin transporter gene expression
A Heils, A Teufel, S Petri, G Stöber, P Riederer, D Bengel, KP Lesch
Journal of neurochemistry 66 (6), 2621-2624, 1996
28211996
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force
EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:
European journal of neurology 19 (3), 360-375, 2012
10662012
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ...
Nature genetics 48 (9), 1043-1048, 2016
5842016
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
HJ Westeneng, TPA Debray, AE Visser, RPA van Eijk, JPK Rooney, ...
The Lancet Neurology 17 (5), 423-433, 2018
4202018
Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB–mediated pathogenic pathways
V Swarup, D Phaneuf, N Dupré, S Petri, M Strong, J Kriz, JP Julien
Journal of Experimental Medicine 208 (12), 2429-2447, 2011
3472011
Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene
A Heils, A Teufel, S Petri, M Seemann, D Bengel, U Balling, P Riederer, ...
Journal of Neural Transmission/General Section JNT 102, 247-254, 1995
3401995
HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients
W Guo, M Naujock, L Fumagalli, T Vandoorne, P Baatsen, R Boon, ...
Nature communications 8 (1), 861, 2017
3372017
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
AC Ludolph, C Bendotti, E Blaugrund, A Chio, L Greensmith, JP Loeffler, ...
Amyotrophic Lateral Sclerosis 11 (1-2), 38-45, 2010
3292010
Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn‐superoxide dismutase mutant mice
M Damiano, AA Starkov, S Petri, K Kipiani, M Kiaei, M Mattiazzi, ...
Journal of neurochemistry 96 (5), 1349-1361, 2006
3062006
ALSFRS-R score and its ratio: a useful predictor for ALS-progression
K Kollewe, U Mauss, K Krampfl, S Petri, R Dengler, B Mohammadi
Journal of the neurological sciences 275 (1-2), 69-73, 2008
2752008
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ...
Nature genetics 53 (12), 1636-1648, 2021
2652021
Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation
M Naumann, A Pal, A Goswami, X Lojewski, J Japtok, A Vehlow, ...
Nature communications 9 (1), 335, 2018
2462018
Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study
T Hagenacker, CD Wurster, R Günther, O Schreiber-Katz, A Osmanovic, ...
The Lancet Neurology 19 (4), 317-325, 2020
2352020
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study
M Graf, D Ecker, R Horowski, B Kramer, P Riederer, M Gerlach, C Hager, ...
Journal of neural transmission 112, 649-660, 2005
2292005
Amyotrophic lateral sclerosis
EL Feldman, SA Goutman, S Petri, L Mazzini, MG Savelieff, PJ Shaw, ...
The Lancet 400 (10360), 1363-1380, 2022
2282022
Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis
M Kiaei, K Kipiani, S Petri, J Chen, NY Calingasan, MF Beal
Neurodegenerative Diseases 2 (5), 246-254, 2006
2242006
Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS
S Petri, S Körner, M Kiaei
Neurology research international 2012, 2012
2162012
Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
A Neymotin, NY Calingasan, E Wille, N Naseri, S Petri, M Damiano, ...
Free Radical Biology and Medicine 51 (1), 88-96, 2011
2122011
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis
M Kiaei, S Petri, K Kipiani, G Gardian, DK Choi, J Chen, NY Calingasan, ...
Journal of Neuroscience 26 (9), 2467-2473, 2006
2042006
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20